Weihai Disu Pharmaceutical Co., LTD

Company Description

Manufacturer and Exporter of API and intermediate, Glipizide, Weihai Disu Pharmaceutical Co., LTD, was incorporated in 2005 with an investment of Approx More Than 1 Billion US Dollar. Having an export rate of almost US$5 Million - US$10 Million in recent times, Weihai Disu Pharmaceutical Co., LTD has been fortifying its network as a significant supplier of Glipizide products in different parts of the world. Weihai Disu Pharmaceutical Co., LTD has been operating since 15 Years . The market share of Weihai Disu Pharmaceutical Co., LTD is approximately around United Arab Emirates,Australia,Canada,Italy,United Kingdom. However, Oceanic and European markets remain untouched, but the industry is planning to open its doors in the European and Oceanic market. Weihai Disu Pharmaceutical Co., LTD is located in Weihai, Shandong, China and is a Private Limited entity with Have Own Export License. The industry has been slowly making waves in the export world with its top-quality products and plans to tap some of the most significant markets in Oceania and Europe.